{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:07:23Z","timestamp":1791799643734,"version":"4.3.4"},"reference-count":21,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Parent Project Muscular Dystrophy"},{"name":"PerkinElmer, Inc."},{"name":"Pfizer, Inc."},{"name":"PTC Therapeutics"},{"name":"Sarepta Therapeutics"},{"name":"Solid Biosciences"},{"name":"Wave Life Sciences"},{"name":"Muscular Dystrophy Association"},{"name":"Sarepta Therapeutics"},{"name":"PerkinElmer, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Pilot studies to detect newborns with Duchenne Muscular Dystrophy (DMD) by newborn bloodspot screening (NBS) have been conducted under the New York State Newborn Screening Program (NYS) and are currently in progress as part of the Early Check Program at Research Triangle Institute (RTI) International. The Newborn Screening Quality Assurance Program (NSQAP) at the U.S. Centers for Disease Control and Prevention (CDC) produced a set of seven prototype dried blood spot (DBS) reference materials spiked with varying levels of creatine kinase MM isoform (CK-MM). These DBS were evaluated over a 3-week period by CDC, NYS, and RTI, all using the same CK-MM isoform-specific fluoroimmunoassay. Results from each laboratory were highly correlated with the relative proportion of CK-MM added to each of the six spiked pools. Based on reference ranges established by NYS and RTI for their pilot studies, these contrived DBS collectively spanned the CK-MM ranges found in typical newborns and the elevated ranges associated with DMD. This set allows quality assessment over the wide range of fluctuating CK-MM levels in typical and DMD-affected newborns.<\/jats:p>","DOI":"10.3390\/ijns9010013","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T06:09:52Z","timestamp":1677564592000},"page":"13","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays"],"prefix":"10.3390","volume":"9","author":[{"given":"Paul","family":"Dantonio","sequence":"first","affiliation":[{"name":"Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-820X","authenticated-orcid":false,"given":"Norma P.","family":"Tavakoli","sequence":"additional","affiliation":[{"name":"Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-8371","authenticated-orcid":false,"given":"Brooke","family":"Migliore","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 27709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McCown","sequence":"additional","affiliation":[{"name":"Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Lim","sequence":"additional","affiliation":[{"name":"Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunju","family":"Park","sequence":"additional","affiliation":[{"name":"Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caggana","sequence":"additional","affiliation":[{"name":"Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-6599","authenticated-orcid":false,"given":"Katerina S.","family":"Kucera","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 27709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Phan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA"},{"name":"Rare Disease Research, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Street","sequence":"additional","affiliation":[{"name":"Birth Monitoring and Research Branch, Division of Birth Defects and Infant Disorders, National Center on Birth Defects & Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-8532","authenticated-orcid":false,"given":"Konstantinos","family":"Petritis","sequence":"additional","affiliation":[{"name":"Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Vogt","sequence":"additional","affiliation":[{"name":"Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13018-022-02996-8","article-title":"Global prevalence of Duchenne and Becker muscular dystrophy: A systematic review and meta-analysis","volume":"17","author":"Salari","year":"2022","journal-title":"J. Orthop. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0009-8981(84)90133-5","article-title":"A rapid screening test for Duchenne muscular dystrophy using dried blood specimens","volume":"138","author":"Orfnos","year":"1984","journal-title":"Clin. Chim. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Parad, R.B., Sheldon, Y., and Bhattacharjee, A. (2021). Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7040077"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","article-title":"Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy","volume":"63","author":"Moat","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Timonen, A., Lloyd-Puryear, M., Hougaard, D.M., Merio, L., Makinen, P., Laitala, V., Polonen, T., Skogstrand, K., Kennedy, A., and Airenne, S. (2019). Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP R Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5030027"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hartnett, M.J., Lloyd-Puryear, M.A., Tavakoli, N.P., Wynn, J., Koval-Burt, C.L., Gruber, D., Trotter, T., Caggana, M., Chung, W.K., and Armstrong, N. (2022). Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8040050"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.27533","article-title":"Creatine Kinase-MM Concentration in Dried Blood Spots from Newborns and Implications for Newborn Screening for Duchenne Muscular Dystrophy","volume":"65","author":"Park","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_9","unstructured":"Kucera, K. (2021, January 5\u201314). Early check implementation of newborn screening for Duchenne and related muscular dystrophies in North Carolina. Proceedings of the 2021 APHL Newborn Screening Symposium, Silver Spring, MD, USA."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12519-017-0036-3","article-title":"Newborn screening for Duchenne muscular dystrophy in China: Follow-up diagnosis and subsequent treatment","volume":"13","author":"Ke","year":"2017","journal-title":"World J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e11071","DOI":"10.1016\/j.heliyon.2022.e11071","article-title":"A Pilot Study of Newborn Screening for Duchenne muscular dystrophy in Guangzhou","volume":"8","author":"Jia","year":"2022","journal-title":"Heliyon."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2022.11.024","article-title":"Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China","volume":"539","author":"Jia","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10072-022-06128-2","article-title":"Duchenne muscular dystrophy newborn screening: The first 50,000 newborns screened in Taiwan","volume":"43","author":"Chien","year":"2022","journal-title":"Neurolog. Sci."},{"key":"ref_14","unstructured":"CLSI (2016). Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality, Clinical and Laboratory Standards Institute. [3rd ed.]. CLSI guideline QMS24."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijns1010013","article-title":"The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality","volume":"1","author":"Mei","year":"2015","journal-title":"Int. J. Neonatal Screen."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hall, K. (2021). 12th ISNS European Regional Meeting Oral and Poster Abstracts. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7040071"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.21037\/jtd.2017.05.81","article-title":"Basic statistics with Microsoft Excel: A review","volume":"9","author":"Divisi","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000\u20132015","volume":"66","author":"Thomas","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Migliore, B.A., Zhou, L., Duparc, M., Robles, V.R., Rehder, C.W., Peay, H.L., and Kucera, K.S. (2022). Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8010012"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.38.6.1039","article-title":"Creatine phosphokinase activity in serum of newborn infants as an indicator of fetal trauma during birth","volume":"38","author":"Rudolph","year":"1966","journal-title":"Pediatrics"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/9\/1\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:44:06Z","timestamp":1760121846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/9\/1\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijns9010013"],"URL":"https:\/\/doi.org\/10.3390\/ijns9010013","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}